Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2014 2
2015 2
2016 3
2017 3
2018 1
2019 5
2020 4
2021 2
2022 5
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Integrative spatial omics reveals distinct tumor-promoting multicellular niches and immunosuppressive mechanisms in African American and European American patients with TNBC.
Zhu Q, Balasubramanian A, Asirvatham JR, Piyarathna DWB, Kaur J, Mohamed N, Wu L, Chatterjee M, Wang S, Pourfarrokh N, Rasaily U, Xu Y, Zheng J, Jebakumar D, Rao A, Chen SH, Li Y, Chang E, Li X, Aneja R, Zhang XH, Sreekumar A. Zhu Q, et al. Among authors: zheng j. bioRxiv [Preprint]. 2024 Mar 31:2024.03.17.585428. doi: 10.1101/2024.03.17.585428. bioRxiv. 2024. PMID: 38562769 Free PMC article. Preprint.
A Phase 2 Study of In Situ Oncolytic Virus Therapy and Stereotactic Body Radiation Therapy Followed by Pembrolizumab in Metastatic Non-Small Cell Lung Cancer.
Guan J, Sun K, Guerrero CA, Zheng J, Xu Y, Mathur S, Teh BS, Farach A, Zhang J, Butler E, Pan PY, Zsigmond E, Mei Z, Mejia J, Chen SH, Chang JC, Bernicker EH. Guan J, et al. Among authors: zheng j. Int J Radiat Oncol Biol Phys. 2024 Apr 1;118(5):1531-1540. doi: 10.1016/j.ijrobp.2023.08.044. Epub 2023 Aug 24. Int J Radiat Oncol Biol Phys. 2024. PMID: 37625523 Clinical Trial.
Aerosolized miR-138-5p and miR-200c targets PD-L1 for lung cancer prevention.
Zhang Q, Pan J, Xiong D, Zheng J, McPherson KN, Lee S, Huang M, Xu Y, Chen SH, Wang Y, Hildebrandt Ruiz L, You M. Zhang Q, et al. Among authors: zheng j. Front Immunol. 2023 Jul 13;14:1166951. doi: 10.3389/fimmu.2023.1166951. eCollection 2023. Front Immunol. 2023. PMID: 37520581 Free PMC article.
36 results